IllnessPrenatal akinesia / hypokinesia, differential diagnosis
Summary
Comprehensive differential diagnostic panel for Prenatal akinesia / hypokinesia containing 12 core candidate genes and altogether 67 curated genes according to the clinical signs
237,0 kb (Extended panel: incl. additional genes)
- Amniotic fluid (after amnocentesis)
- Chorionic villus
- Umbilical cord blood
NGS +
Gene panel
Selected genes
Name | Exon Length (bp) | OMIM-G | Referenz-Seq. | Heredity |
---|---|---|---|---|
ASCC1 | 1074 | NM_001198800.3 | AR | |
BICD2 | 2568 | NM_001003800.2 | AR | |
CHRNA1 | 1374 | NM_000079.4 | AD, AR | |
CHRND | 1554 | NM_000751.3 | AR | |
CHRNG | 1554 | NM_005199.5 | AR | |
CNTN1 | 3057 | NM_001843.4 | AR | |
DOK7 | 1515 | NM_173660.5 | AR | |
ERCC6 | 4482 | NM_000124.4 | AR | |
GBE1 | 2109 | NM_000158.4 | AR | |
MUSK | 2610 | NM_005592.4 | AR | |
MYOD1 | 963 | NM_002478.5 | AR | |
RAPSN | 1239 | NM_005055.5 | AR | |
CACNA1S | 5622 | NM_000069.3 | AD, AR | |
CNTNAP1 | 4155 | NM_003632.3 | AR | |
DMPK | 1920 | NM_001081563.2 | AD | |
DNM2 | 2613 | NM_001005360.3 | AR, AD | |
ECEL1 | 2328 | NM_004826.4 | AR | |
ERCC1 | 972 | NM_202001.3 | AR | |
ERCC2 | 2283 | NM_000400.4 | AR | |
ERCC3 | 2349 | NM_000122.2 | AR | |
FKTN | 1386 | NM_001079802.2 | AR | |
GLE1 | 2097 | NM_001003722.2 | AR | |
HRAS | 570 | NM_005343.4 | AD | |
IRF6 | 1404 | NM_006147.4 | AD | |
LGI4 | 1614 | NM_139284.3 | AR | |
LMNA | 1995 | NM_170707.4 | AD, AR | |
MAGEL2 | 3750 | NM_019066.5 | AD | |
MYBPC1 | 3516 | NM_002465.4 | AD, AR | |
MYH3 | 5823 | NM_002470.4 | AD | |
MYH8 | 5814 | NM_002472.3 | AD | |
NUP88 | 2291 | NM_002532.6 | AR | |
PIEZO2 | 8259 | NM_022068.4 | AD, AR | |
RIPK4 | 2355 | NM_020639.3 | AR | |
RYR1 | 15117 | NM_000540.3 | AD, AR | |
SMN1 | 885 | NM_000344.4 | AR | |
SYNE1 | 26250 | NM_033071.4 | AR | |
TNNI2 | 549 | NM_003282.4 | AD | |
TPM2 | 855 | NM_003289.4 | AD | |
TRIP4 | 1759 | NM_016213.5 | AR | |
TTN | 100272 | NM_001267550.2 | AR | |
VIPAS39 | 1482 | NM_022067.4 | AR | |
VPS33B | 1854 | NM_018668.5 | AR | |
ZC4H2 | 675 | NM_018684.4 | XL |
Informations about the disease
Multiple joint contractures, facial anomalies, pulmonary hypoplasia. Common feature is decreased foetal activity
- Alias: Fetal akinesia deformation sequence
- Alias: Prenatal akiesia/hypokinesia
- Allelic: Barrett esophagus/esophageal adenocarcinoma (ASCC1)
- Allelic: CAP myopathy 2 (TPM2)
- Allelic: CHAND syndrome (RIPK4)
- Allelic: Cardiomyopathy, dilated, 1G (TTN)
- Allelic: Cardiomyopathy, familial hypertrophic, 9 (TTN)
- Allelic: Cockayne syndrome, type B (ERCC6)
- Allelic: Costello syndrome (HRAS)
- Allelic: De Sanctis-Cacchione syndrome (ERCC6)
- Allelic: Emery-Dreifuss muscular dystrophy 4, AD (SYNE1)
- Allelic: Erythroleukemia, familial, susceptibility to (ERBB3)
- Allelic: Fibrosis of extraocular muscles, congenital, 1 (KIF21A)
- Allelic: Fibrosis of extraocular muscles, congenital, 3B (KIF21A)
- Allelic: Heart-hand syndrome, Slovenian type (LMNA)
- Allelic: Hutchinson-Gilford progeria (LMNA)
- Allelic: Intellectual developmental disorder, AD 56 (CLTC)
- Allelic: Lipodystrophy, familial partial, type 2 (LMNA)
- Allelic: Malignant hyperthermia susceptibility 1 (RYR1)
- Allelic: Malignant hyperthermia susceptibility 5 (CACNA1S)
- Allelic: Malouf syndrome (LMNA)
- Allelic: Mandibuloacral dysplasia (LMNA)
- Allelic: Nemaline myopathy 4, AD (TPM2)
- Allelic: Orofacial cleft 6 (IRF6)
- Allelic: Polyglucosan body disease, adult form (GBE1)
- Allelic: Premature ovarian failure 11 (ERCC6)
- Allelic: Spinocerebellar ataxia, AR 8 (SYNE1)
- Allelic: Thyrotoxic periodic paralysis, susceptibility to, 1 (CACNA1S)
- Allelic: Trichothiodystrophy 1, photosensitive (ERCC2)
- Allelic: UV-sensitive syndrome 1 (ERCC6)
- Allelic: Xeroderma pigmentosum, group D (ERCC2)
- Allelic: van der Woude syndrome (IRF6)
- Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis (FGFR2)
- Arthrogryposis [MONDO:0008779; panelapp] (KIF21A)
- Arthrogryposis [panelapp] (UTRN)
- Arthrogryposis multiplex congenita 1, neurogenic, with myelin defect (LGI4)
- Arthrogryposis multiplex congenita 2, neurogenic type (ERGIC1)
- Arthrogryposis multiplex congenita 6 (NEB)
- Arthrogryposis multiplex congenita [panelapp] (UNC50)
- Arthrogryposis multiplex congenita-pulmonary hypoplasia syndrome
- Arthrogryposis, distal, type 1A (TPM2)
- Arthrogryposis, distal, type 1B (MYBPC1)
- Arthrogryposis, distal, type 2A [Freeman-Sheldon] (MYH3)
- Arthrogryposis, distal, type 2B1 (TNNI2)
- Arthrogryposis, distal, type 2B2 (TNNT3)
- Arthrogryposis, distal, type 2B3 [Sheldon-Hall] (MYH3)
- Arthrogryposis, distal, type 2B4 (TPM2)
- Arthrogryposis, distal, type 3 (PIEZO2)
- Arthrogryposis, distal, type 5 (PIEZO2)
- Arthrogryposis, distal, type 5D (ECEL1)
- Arthrogryposis, distal, with impaired proprioception + touch (PIEZO2)
- Arthrogryposis, renal dysfunction, and cholestasis 1 (VPS33B)
- Arthrogryposis, renal dysfunction, cholestasis 2 (VIPAS39)
- Cardiomyopathy, dilated, 1A (LMNA)
- Carney complex variant (MYH8)
- Central core disease (RYR1)
- Centronuclear myopathy 1 (DNM2)
- Centronuclear myopathy 2 (BIN1)
- Cerebro-oculo-facio-skeletal (COFS) syndrome (ERCC6)
- Cerebrooculofacioskeletal syndrome 1 (ERCC6)
- Cerebrooculofacioskeletal syndrome 2 (ERCC2)
- Cerebrooculofacioskeletal syndrome 4 (ERCC1)
- Charcot-Marie-Tooth disease, DI B (DNM2)
- Charcot-Marie-Tooth disease, axonal type 2M (DNM2)
- Charcot-Marie-Tooth disease, type 2B1 (LMNA)
- Congenital arthrogryposis with anterior horn cell disease (GLE1)
- Congenital disorder of glycosylation, type Ij (DPAGT1)
- Congenital myopathy with excess of muscle spindles (HRAS)
- Contractures, pterygia + spondylocarpotarsal fusion syndrome 1A (MYH3)
- Contractures, pterygia + spondylocarpotarsal fusion syndrome 1B (MYH3)
- Cortical dysplasia, complex, with other brain malformations 7 (TUBB2B)
- Emery-Dreifuss muscular dystrophy 2, AD (LMNA)
- Emery-Dreifuss muscular dystrophy 3, AR (LMNA)
- Escobar syndrome (CHRNG)
- Fetal akinesia [panelapp] (KIF21A)
- Fetal akinesia deformation sequence 1 (MUSK)
- Fetal akinesia deformation sequence 2 (RAPSN)
- Fetal akinesia deformation sequence 3 (DOK7)
- Fetal akinesia, growth restriction [panelapp] (CLTC)
- Glycogen storage disease IV (GBE1)
- Hyperkalemic periodic paralysis, type 2 (SCN4A)
- Hypokalemic periodic paralysis, type 1 (CACNA1S)
- Hypokalemic periodic paralysis, type 2 (SCN4A)
- Hypomyelinating neuropathy, congenital, 3 (CNTNAP1)
- King-Denborough syndrome (RYR1)
- Lethal congenital contracture syndrome 1 (GLE1)
- Lethal congenital contracture syndrome 2 (ERBB3)
- Lethal congenital contracture syndrome 3 (PIP5K1C)
- Lethal congenital contracture syndrome 4 (MYBPC1)
- Lethal congenital contracture syndrome 5 (DNM2)
- Lethal congenital contracture syndrome 6 (ZBTB42)
- Lethal congenital contracture syndrome 7 (CNTNAP1)
- Lethal congenital contracture syndrome 8 (ADCY6)
- Lethal congenital contracture syndrome 9 (ADGRG6)
- Marden-Walker syndrome (PIEZO2)
- Minicore myopathy with external ophthalmoplegia (RYR1)
- Multiple pterygium syndrome, lethal type (CHRNA1, CHRND)
- Multiple pterygium syndrome, lethal type (CHRNG)
- Muscular dystrophy, congenital (LMNA)
- Muscular dystrophy, congenital, Davignon-Chauveau type (TRIP4)
- Muscular dystrophy, limb-girdle, AR (TTN)
- Muscular dystrophy-dystroglycanopathy (cong. with brain + eye anomalies), type A, 4 (FKTN)
- Muscular dystrophy-dystroglycanopathy (cong. with brain + eye anomalies), type A, 5 (FKRP)
- Muscular dystrophy-dystroglycanopathy (cong. with/-out mental retardation), type B, 5 (FKRP)
- Muscular dystrophy-dystroglycanopathy (cong. without mental retardation), type B, 4 (FKTN)
- Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 4 (FKTN)
- Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 5 (FKRP)
- Myasthenic syndrome, congenital, 10 (DOK7)
- Myasthenic syndrome, congenital, 11, ass. w. acetylcholine receptor deficiency (RAPSN)
- Myasthenic syndrome, congenital, 13, with tubular aggregates (DPAGT1)
- Myasthenic syndrome, congenital, 16 (SCN4A)
- Myasthenic syndrome, congenital, 1A, slow-channel (CHRNA1)
- Myasthenic syndrome, congenital, 1B, fast-channel (CHRNA1)
- Myasthenic syndrome, congenital, 21, presynaptic (SLC18A3)
- Myasthenic syndrome, congenital, 3A, slow-channel (CHRND)
- Myasthenic syndrome, congenital, 3B, fast-channel (CHRND)
- Myasthenic syndrome, congenital, 3C, ass. w. acetylcholine receptor deficiency (CHRND)
- Myasthenic syndrome, congenital, 9, ass. w. acetylcholine receptor deficiency (MUSK)
- Myopathy, XL, with excessive autophagy (VMA21)
- Myopathy, actin, congenital, with cores (ACTA1)
- Myopathy, actin, congenital, with excess of thin myofilaments (ACTA1)
- Myopathy, centronuclear, XL (MTM1)
- Myopathy, cong., diaphragmatic defects, respiratory insufficiency, dysmorphic face (MYOD1)
- Myopathy, congenital, Compton-North (CNTN1)
- Myopathy, congenital, with fiber-type disproportion 1 (ACTA1)
- Myopathy, congenital, with tremor (MYBPC1)
- Myopathy, myofibrillar, 9, with early respiratory failure (TTN)
- Myopathy, scapulohumeroperoneal (ACTA1)
- Myotonia congenita, atypical, acetazolamide-responsive (SCN4A)
- Myotonic dystrophy 1 (DMPK_CTG)
- Nemaline myopathy 10 (LMOD3)
- Nemaline myopathy 2, AR (NEB)
- Nemaline myopathy 3, AD/AR (ACTA1)
- Nemaline myopathy 8, AR (KLHL40)
- Nemaline myopathy 9 (KLHL41)
- Neuromuscular disease, congenital, with uniform type 1 fiber (RYR1)
- Paramyotonia congenita (SCN4A)
- Pena Shokeir I/II syndromes
- Popliteal pterygium syndrome 1 (IRF6)
- Popliteal pterygium syndrome, Bartsocas-Papas type (RIPK4)
- Restrictive dermopathy 2 (LMNA)
- Salih myopathy (TTN)
- Schaaf-Yang syndrome (MAGEL2)
- Spinal muscular atrophy with congenital bone fractures 1 (TRIP4)
- Spinal muscular atrophy with congenital bone fractures 2 (ASCC1)
- Spinal muscular atrophy, XL 2, infantile (UBA1)
- Spinal muscular atrophy, lower extremity-predominant, 2A + 2B, AD (BICD2)
- Spinal muscular atrophy-1, -2, -3, -4 (SMN1)
- Tibial muscular dystrophy, tardive (TTN)
- Trismus-pseudocamptodactyly syndrome (MYH8)
- Visceral neuropathy, familial, 1, AR (ERBB3)
- Wieacker-Wolff syndrome (ZC4H2)
- Wieacker-Wolff syndrome, female-restricted (ZC4H2)
- AD
- AR
- XL
- Multiple OMIM-Ps
Bioinformatics and clinical interpretation
Test-Stärken
- DAkkS-akkreditiertes Labor
- EU-Richtlinie für IVD in Umsetzung
- Qualitäts-kontrolliert arbeitendes Personal
- Leistungsstarke Sequenzierungstechnologien, fortschrittliche Target-Anreicherungsmethoden und Präzisions-Bioinformatik-Pipelines sorgen für überragende analytische Leistung
- Sorgfältige Kuratierung klinisch relevanter und wissenschaftlich begründeter Gen-Panels
- eine Vielzahl nicht Protein-kodierender Varianten, die in unseren klinischen NGS-Tests mit erfasst werden
- unser strenges Variantenklassifizierungsschema nach ACMG-Kriterien
- unser systematischer klinischer Interpretations-Workflow mit proprietärer Software ermöglicht die genaue und nachvollziehbare Verarbeitung von NGS-Daten
- unsere umfassenden klinischen Aussagen
Testeinschränkungen
- Gene mit eingeschränkter Abdeckung werden gekennzeichnet
- Gene mit kompletten oder partiellen Duplikationen werden gekennzeichnet
- es wird angenommen, dass ein Gen suboptimal abgedeckt ist, wenn >90% der Nukleotide des Gens bei einem Mapping-Qualitätsfaktor von >20 (MQ>20) nicht abgedeckt sind
- die Sensitivität der Diagnostik zur Erkennung von Varianten mit genannten Testeinschränkungen ist möglicherweise begrenzt bei:
- Gen-Konversionen
- komplexe Inversionen
- Balancierte Translokationen
- Mitochondriale Varianten
- Repeat-Expansionen, sofern nicht anders dokumentiert
- nicht kodierende Varianten, die Krankheiten verursachen, die von diesem Panel nicht mit abgedeckt werden
- niedriger Mosaik-Status
- Repeat-Blöcke von Mononukleotiden
- Indels >50bp (Insertionen-Deletionen)
- Deletionen oder Duplikationen einzelner Exons
- Varianten innerhalb von Pseudogenen
- die analytische Sensitivität kann geringer ausfallen werden, wenn die DNA nicht von amedes genetics extrahiert wurde
Laboratory requirement
Die in grün gezeigten Gene sind kuratiert und werden als Gen-Panel untersucht. Eine Erweiterung des Panels (blau gezeigte Gene, jeweils ebenfalls kuratiert) kann auf Anfrage erfolgen. Sofern unter "Erweitertes Panel" ein Minuszeichen angezeigt wird, sind nur Core-/Basis-Gene verfügbar.
Für die Anforderung einer genetischen Untersuchung senden Sie uns bitte die Krankheits-ID auf einem Überweisungsschein. Bitte die Material-Angabe beachten.
Für privat versicherte Patienten empfehlen wir einen Antrag auf Kostenübernahme bei der Krankenversicherung.
Die Untersuchung wird auch für Selbstzahler angeboten.